Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 spesolimab trial in Japan
jRCT2080225337Phase 2Not yet recruiting
- Start
- Aug 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of spesolimab. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
spesolimab
Beyond the preview
Go deeper on jRCT2080225337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225337.